USE OF EGFR/HER2 TYROSINE KINASE INHIBITORS AND/OR HER2/HER3 ANTIBODIES FOR THE TREATMENT… Application EP-4097261-A4 European Patent Office 18 Oct 2023
USE OF QUINAZOLINE-BASED TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCERS WITH… Application EP-4097140-A4 European Patent Office 18 Oct 2023
TREATMENT AND PREVENTION OF CANCER USING HER3 ANTIGEN-BINDING MOLECULES Application WO-2023031435-A1 World Intellectual Property Organisation (WIPO) 09 Mar 2023
Compounds, compositions and methods for treating or preventing HER-driven drug-resistant… Grant US-11426409-B2 United States of America 30 Aug 2022